エディションの選択
国
重点項目
病状
組織の種類
ステークホルダー
品質
Third Edition BOGP (10)
ドイツ (2)
Education (awareness, health promotion)
Musculoskeletal/Multiple Sclerosis (MS) (1)
Private Public Partnership (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Transparency in communication and documentation
Clinical study phase II